{"id":824,"date":"2025-02-27T10:21:55","date_gmt":"2025-02-27T10:21:55","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/?page_id=824"},"modified":"2025-04-03T17:18:51","modified_gmt":"2025-04-03T17:18:51","slug":"inmunizacion-basada-en-peptidos-para-el-carcinoma-de-colon-y-pancreas-picop-global","status":"publish","type":"page","link":"https:\/\/www.centogene.com\/es\/pharma\/clinical-trial-support\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\/","title":{"rendered":"PiCoP-GLOBAL"},"content":{"rendered":"<section class=\"bloque-banner-titulo-page  estilo-grey\" id=\"\">\r\n    \r\n    <div class=\"image-wrapper\">\r\n\r\n      <!-- include mp4 video on a loop -->\r\n              <img decoding=\"async\" class=\"\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/csm_centogene-pharma-clinical-trails_PiCoP-global-header_f7e9060779.webp\" alt=\"csm_centogene-pharma-clinical-trails_PiCoP-global-header_f7e9060779\" \/>\r\n          <\/div>\r\n    <div class=\"container content-wrapper\">\r\n      <div class=\"row justify-content-start align-items-center\">\r\n\r\n\r\n        <div class=\"col-12 col-lg-6 animation fadeTop align-self-center\">\r\n                  <h1>PiCoP-GLOBAL<\/h1>\r\n          <h2 class=\"bl-texto\">Inmunizaci\u00f3n basada en p\u00e9ptidos para el carcinoma de colon y p\u00e1ncreas<\/h2>                            <\/div>\r\n\r\n      <\/div>\r\n    <\/div>\r\n\r\n<\/section>\r\n<div class=\"breadcrumbs\">\r\n    <div class=\"container\">\r\n      <div class=\"row\">\r\n        <div class=\"col-12\">\r\n          <ul id=\"breadcrumbs\" class=\"breadcrumbs\"><li><a href=\"https:\/\/www.centogene.com\/es\/\">Inicio<\/a><\/li><\/ul>        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Resumen<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Descripci\u00f3n general<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PiCoP-GLOBAL es un estudio epidemiol\u00f3gico observacional multic\u00e9ntrico internacional cuyo objetivo es desarrollar herramientas diagn\u00f3sticas para terapias inmunitarias personalizadas en tumores de colon y p\u00e1ncreas. Este estudio est\u00e1 estrechamente vinculado al estudio nacional PiCoP en Alemania y a un estudio de seguimiento sobre vacunaci\u00f3n.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El estudio de inmunizaci\u00f3n basada en p\u00e9ptidos para el carcinoma de colon y p\u00e1ncreas (PiCoP-GLOBAL) es un estudio observacional global centrado en la identificaci\u00f3n de neoant\u00edgenos espec\u00edficos del tumor como base para desarrollar una terapia inmunol\u00f3gica personalizada dirigida a la respuesta inmunitaria del propio paciente contra el tumor.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">    <section class=\"bloque-personalizado bloque-cajas-imgs estilo-cajasblancas\" >\n        <div class=\"\"> \n                        <div class=\"row justify-content-between\">\n\n                                        \n                <div class=\"swiper-slide col-12 delay-1 caja\">\n                    <div class=\"caja-inner\" >\n                        <a href=\"https:\/\/www.centoportal.com\/\" target=\"_blank\" class=\"\">                        <div class=\"bl-imagen animationNo scalexTop delay-1\"><img decoding=\"async\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/csm_centogene-pharma-clinical-trials_study-access-teaser-card_7fbd33e2a0-650x400.webp\" class=\"\" alt=\"\" \/> <\/div>                                               \n                        <\/a>                        \n                        <div class=\"caja-text\">\n                            <p class=\"prefijo\">Ensayos cl\u00ednicos<\/p>                            <h3 class=\"bl-titulo\">Acceso al estudio en CentoPortal\u00ae para los m\u00e9dicos participantes<\/h3>\n                                  \n                                                          <a target=\"_blank\" href=\"https:\/\/www.centoportal.com\/\" class=\"btn btn-primary\">CentoPortal\u00ae<\/a>\n                                                                          \n                        <\/div>                        \n                        \n                    <\/div>      \n                <\/div>       \n                \n                                     \n             \n            \n        <\/div>\n    <\/div>  \n<\/section>\n\n\n\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    fondocolor\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<h2 class=\"wp-block-heading\">Fundamento y dise\u00f1o del estudio<\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\">Fundamento del estudio<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">El tratamiento est\u00e1ndar para el c\u00e1ncer de colon y p\u00e1ncreas depende del estadio e incluye cirug\u00eda, quimioterapia y radioterapia. Sin embargo, dado que el pron\u00f3stico de los tumores avanzados de colon y p\u00e1ncreas, en general, es muy malo, existe una necesidad urgente de mejorar el tratamiento.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La mejora de la respuesta inmunitaria mediante la vacunaci\u00f3n se encuentra entre las nuevas opciones terap\u00e9uticas, ya sea mediante el uso de ant\u00edgenos celulares espec\u00edficos, ant\u00edgenos tumorales espec\u00edficos sobreexpresados o ant\u00edgenos tumorales espec\u00edficos mutados (neoep\u00edtopos). El mayor potencial de alta especificidad, aunque presupone una caracterizaci\u00f3n exhaustiva del tumor respectivo, reside en los ant\u00edgenos tumorales espec\u00edficos mutados. Para identificar un enfoque de vacunaci\u00f3n basado en neoep\u00edtopos para opciones de tratamiento individualizadas para cada paciente, es necesario analizar previamente las caracter\u00edsticas moleculares de los tumores.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Los participantes del estudio tendr\u00e1n acceso a informes m\u00e9dicos con mutaciones som\u00e1ticas relacionadas con el diagn\u00f3stico de c\u00e1ncer a trav\u00e9s de sus m\u00e9dicos.<\/li>\n\n\n\n<li>En caso de que se encuentren neoant\u00edgenos adecuados para la producci\u00f3n de vacunas individuales para pacientes, es posible la inscripci\u00f3n en el estudio cl\u00ednico de seguimiento.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Todos los pacientes que participen en PiCoP-GLOBAL har\u00e1n una contribuci\u00f3n importante a la comprensi\u00f3n de los tumores de colon y p\u00e1ncreas y al posible desarrollo de opciones de tratamiento individualizadas.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\">Dise\u00f1o del estudio<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Los participantes que cumplan los criterios de inclusi\u00f3n se inscribir\u00e1n en el estudio tras otorgar su consentimiento informado. Durante la cirug\u00eda convencional para extirpar el tumor, se les extraer\u00e1 una muestra de sangre para la investigaci\u00f3n. Del tejido extirpado durante la cirug\u00eda, se obtendr\u00e1n una muestra de tumor y una muestra de tejido de control para el estudio.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Es posible que se tomen muestras de sangre adicionales en diferentes momentos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Todos los materiales se env\u00edan a CENTOGENE y se analizan en el laboratorio de CENTOGENE en Alemania.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Las muestras se analizar\u00e1n gen\u00e9ticamente para detectar mutaciones asociadas a tumores y mediante espectrometr\u00eda de masas (MS\/MS) para neoep\u00edtopos y estudios de biomarcadores. Los datos recopilados se utilizar\u00e1n en un enfoque multi\u00f3mico para predecir neoep\u00edtopos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Las muestras de sangre de seguimiento se analizar\u00e1n gen\u00e9ticamente y mediante un monitoreo inmunol\u00f3gico espec\u00edfico para verificar una respuesta inmune preexistente contra neoant\u00edgenos en pacientes no vacunados, para monitorear la respuesta inmune de los pacientes durante la quimioterapia y para monitorear la respuesta de los pacientes al tratamiento.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A cualquier paciente en el que se encuentren neoant\u00edgenos prometedores para la producci\u00f3n de vacunas se le podr\u00eda ofrecer participar en un futuro estudio cl\u00ednico.<\/p>\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Informaci\u00f3n sobre el estudio<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dise\u00f1o:<\/strong>&nbsp;Estudio epidemiol\u00f3gico internacional observacional no intervencionista<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Poblaci\u00f3n de estudio:<\/strong>&nbsp;Pacientes con carcinoma de p\u00e1ncreas o colorrectal sometidos a cirug\u00eda<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>N\u00famero de pacientes:&nbsp;<\/strong>100 participantes<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Primer paciente en:<\/strong>&nbsp;Abril de 2019<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00daltimo paciente en:&nbsp;<\/strong>Junio de 2021<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Periodo de inclusi\u00f3n:<\/strong>&nbsp;24 meses<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Objetivos:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Identificaci\u00f3n de mutaciones espec\u00edficas de tumores a nivel gen\u00f3mico.<\/li>\n\n\n\n<li>Validaci\u00f3n de mutaciones espec\u00edficas de tumores a nivel transcripcional y\/o traduccional.<\/li>\n\n\n\n<li>Desarrollo de una estrategia de vacunaci\u00f3n personalizada.<\/li>\n\n\n\n<li>Desarrollo de estrategias diagn\u00f3sticas de seguimiento.<\/li>\n\n\n\n<li>Establecimiento de biomarcadores en pacientes con carcinoma de p\u00e1ncreas o colon.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Apuntar:<\/strong>&nbsp;Desarrollo de opciones de tratamiento individualizadas para tumores de colon y p\u00e1ncreas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Descubre c\u00f3mo puedes participar:&nbsp;<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03871790?term=picop&amp;rank=1\" target=\"_blank\" rel=\"noreferrer noopener\">ClinicalTrials.gov<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Criterios de inclusi\u00f3n<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Criterios de inclusi\u00f3n<\/th><\/tr><\/thead><tbody><tr><td>Se obtiene el consentimiento informado del participante.<\/td><\/tr><tr><td>Pacientes con carcinoma de p\u00e1ncreas o colorrectal sometidos a cirug\u00eda<\/td><\/tr><tr><td>El participante es mayor de 18 a\u00f1os.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Socios de cooperaci\u00f3n<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CENTOGENE colabora en este proyecto con empresas biotecnol\u00f3gicas, la Universidad de Rostock y la Universidad de Greifswald en el estudio PiCoP, posible gracias a la cofinanciaci\u00f3n del Fondo Europeo de Desarrollo Regional (FEDER). Adem\u00e1s de reclutar pacientes, ambas universidades contribuyen mediante proyectos cient\u00edficos para estudios de la v\u00eda PI3K\/ATK\/mTOR, el establecimiento de l\u00edneas celulares o modelos de trasplante, la monitorizaci\u00f3n inmunitaria y el an\u00e1lisis de perfiles epigen\u00e9ticos en tejido de c\u00e1ncer de colon.<\/p>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">CENTOGENE tambi\u00e9n colabora con socios internacionales en el estudio global PiCoP, cuyo primer centro internacional se incorpor\u00f3 en abril de 2019 con socios en Pakist\u00e1n (todos miembros de la <a href=\"http:\/\/www.sospk.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Sociedad de Oncolog\u00eda Quir\u00fargica de Pakist\u00e1n<\/a> ).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Datos sobre las enfermedades<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Datos sobre el carcinoma colorrectal*<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>El c\u00e1ncer colorrectal es la cuarta causa m\u00e1s com\u00fan de muerte por c\u00e1ncer en todo el mundo: se estima que hay 694.000 muertes al a\u00f1o.<\/li>\n\n\n\n<li>Los c\u00e1nceres colorrectales abarcan tumores que aparecen tanto en el colon como en el recto.<\/li>\n\n\n\n<li>Uno de los tipos de c\u00e1ncer m\u00e1s comunes en todo el mundo: 10% de la carga mundial de incidencia de c\u00e1ncer en 2012<\/li>\n\n\n\n<li>El tercer c\u00e1ncer m\u00e1s com\u00fan en hombres (se estima que hay 746.000 casos nuevos al a\u00f1o)<\/li>\n\n\n\n<li>El segundo caso m\u00e1s com\u00fan en mujeres (se estima que hay 614.000 casos nuevos al a\u00f1o)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Datos sobre el carcinoma de p\u00e1ncreas*<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Debido a su mal pron\u00f3stico, el c\u00e1ncer de p\u00e1ncreas es la s\u00e9ptima causa m\u00e1s com\u00fan de muerte por c\u00e1ncer en todo el mundo.<\/li>\n\n\n\n<li>Se estima que fue el duod\u00e9cimo c\u00e1ncer m\u00e1s com\u00fan en hombres (178.000 casos) y el und\u00e9cimo m\u00e1s com\u00fan en mujeres (160.000 casos) en todo el mundo en 2012.<\/li>\n\n\n\n<li>El 68% de los nuevos casos se produjeron en pa\u00edses con niveles altos o muy altos de desarrollo econ\u00f3mico humano.<\/li>\n\n\n\n<li>Se estima que hubo 330.000 muertes por c\u00e1ncer de p\u00e1ncreas en 2012<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">*Fuente: Estimaciones <a href=\"https:\/\/www.drugsandalcohol.ie\/28525\/1\/WorldCancerReport.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">del Informe Mundial sobre el C\u00e1ncer de la OMS de 2014<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<h5 class=\"wp-block-heading\">Recursos<\/h5>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Enlaces \u00fatiles<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03871790?term=picop&amp;rank=1\" target=\"_blank\" rel=\"noreferrer noopener\">Descubra c\u00f3mo puede participar: ClinicalTrials.gov<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/sospk.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Sociedad de Oncolog\u00eda Quir\u00fargica de Pakist\u00e1n<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.drugsandalcohol.ie\/28525\/1\/World%20Cancer%20Report.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Informe mundial sobre el c\u00e1ncer de la OMS 2014<\/a><\/p>\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n  <section class=\"bloque-personalizado bloque-contact-info\" >     \n    <h2 class=\"mt-3 mb-5\"> Contacto Estudio PiCoP-GLOBAL<\/h2>   \n    <div class=\"row justify-content-center bordesverticales\"> \n        <div class=\"bl-texto col-12 col-md-3\">\n         <h5 class=\"mt-0\">Para m\u00e1s informaci\u00f3n por favor contactar<\/h5>\n<p><strong>Prof. Dr. Peter Bauer, Director del Proyecto<\/strong><br \/>\nCENTOGENE GmbH<br \/>\nAm Strande 7<br \/>\n18055 Rostock<br \/>\nAlemania<br \/>\nCorreo electr\u00f3nico:<a title=\"Escribe un correo electr\u00f3nico\" href=\"mailto:peter.bauer@centogene.com\" > peter.bauer@centogene.com<\/a><\/p>\n<p><strong>Dra. Susann Krake, directora de proyectos<\/strong>r<br \/>\nCENTOGENE GmbH<br \/>\nAm Strande 7<br \/>\n18055 Rostock<br \/>\nAlemania<br \/>\nCorreo electr\u00f3nico: <a title=\"Escribe un correo electr\u00f3nico\" href=\"mailto:susann.krake@centogene.com\">susann.krake@centogene.com<\/a><\/p>\n        <\/div>\n        <div class=\"bl-texto  col-12 col-md-2\">\n          \n        <\/div>\n        <div class=\"bl-texto  col-12 col-md-3\">\n          <h5 class=\"mt-0\">Ensayos cl\u00ednicos<\/h5>\n<h4 class=\"translation-block\">Acceso al estudio en CentoPortal <sup>\u00ae<\/sup> para los m\u00e9dicos participantes.<\/h4>\n<p><a class=\"btn btn-primary\" title=\"CentoPortal\" href=\"https:\/\/login.centoportal.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">CentoPortal<\/a><\/p>\n        <\/div>\n    <\/div>\n  <\/section>  \n\n  \n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":1078,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-824","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PiCoP-GLOBAL | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/inmunizacion-basada-en-peptidos-para-el-carcinoma-de-colon-y-pancreas-picop-global\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PiCoP-GLOBAL | CENTOGENE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/inmunizacion-basada-en-peptidos-para-el-carcinoma-de-colon-y-pancreas-picop-global\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-03T17:18:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\\\/\",\"name\":\"PiCoP-GLOBAL | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2025-02-27T10:21:55+00:00\",\"dateModified\":\"2025-04-03T17:18:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trial Support\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"PiCoP-GLOBAL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PiCoP-GLOBAL | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/inmunizacion-basada-en-peptidos-para-el-carcinoma-de-colon-y-pancreas-picop-global\/","og_locale":"es_ES","og_type":"article","og_title":"PiCoP-GLOBAL | CENTOGENE","og_url":"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/inmunizacion-basada-en-peptidos-para-el-carcinoma-de-colon-y-pancreas-picop-global\/","og_site_name":"CENTOGENE","article_modified_time":"2025-04-03T17:18:51+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\/","url":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\/","name":"PiCoP-GLOBAL | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2025-02-27T10:21:55+00:00","dateModified":"2025-04-03T17:18:51+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/peptide-based-immunization-for-colon-and-pancreas-carcinoma-picop-global\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"Pharma","item":"https:\/\/www.centogene.com\/pharma\/"},{"@type":"ListItem","position":3,"name":"Clinical Trial Support","item":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/"},{"@type":"ListItem","position":4,"name":"PiCoP-GLOBAL"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=824"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/824\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/1078"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}